Literature DB >> 21050771

Tear cytokines and chemokines in patients with Demodex blepharitis.

Jee Taek Kim1, Seok Hyun Lee, Yeoun Sook Chun, Jae Chan Kim.   

Abstract

PURPOSE: The purpose of the study is to evaluate the causes of inflammation in Demodex-induced blepharitis by analyzing cytokine levels in lacrimal fluid.
METHODS: Fifteen Demodex blepharitis patients were selected for assessment of tear cytokine concentrations. Fifteen Demodex-free blepharitis patients and 15 subjects with no ocular symptoms were selected as control groups. Minimally stimulated tear samples (20μl) were collected from each eye and analyzed using a Luminex® 200™ Total System for detection of IL-1β, IL-5, IL-7, IL-12, IL-13, IL-17, granulocyte colony-stimulating factor (G-CSF), and macrophage inflammatory protein-1 beta (MIP-1β).
RESULTS: The concentration of IL-17 in tears was significantly higher in the Demodex blepharitis group than in the Demodex-free blepharitis group. Tear IL-7 and IL-12 levels show serial increases for these three groups (p<0.05). There were no significant differences in the other cytokines levels between both blepharitis groups. We confirmed that elevated cytokines normalized after treatments.
CONCLUSIONS: Infestation of Demodex mites induces change of tear cytokine levels, IL-17 especially, which cause inflammation of the lid margin and ocular surface. These findings might increase our understanding of the mechanism of ocular discomfort and telangiectasias frequently found in Demodex blepharitis patients.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21050771     DOI: 10.1016/j.cyto.2010.08.009

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  19 in total

Review 1.  Rosacea: The cytokine and chemokine network.

Authors:  Peter Arne Gerber; Bettina Alexandra Buhren; Martin Steinhoff; Bernhard Homey
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

Review 2.  [Blepharitis component of dry eye syndrome].

Authors:  C Auw-Hädrich; T Reinhard
Journal:  Ophthalmologe       Date:  2018-02       Impact factor: 1.059

3.  Periodic acid-Schiff staining demonstrates fungi in chronic anterior blepharitis.

Authors:  Z Dadaci; F Kılınç; T T Ozer; G O Sahin; N O Acir; M Borazan
Journal:  Eye (Lond)       Date:  2015-08-21       Impact factor: 3.775

Review 4.  A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain.

Authors:  Harrison Dermer; Daniella Lent-Schochet; Despoina Theotoka; Christian Paba; Abdullah A Cheema; Ryan S Kim; Anat Galor
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

5.  The association between demodex infestation and ocular surface manifestations in meibomian gland dysfunction.

Authors:  Xiao-Bo Zhang; Ying-Hui Ding; Wei He
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

6.  Clinical efficacy of combined topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in the dry eyes with meibomian gland dysfunction.

Authors:  Ho-Yun Kim; Ji-Eun Lee; Ha-Na Oh; Ju-Whan Song; Sang-Youp Han; Jong-Soo Lee
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

Review 7.  [Current insights into the pathophysiology of rosacea].

Authors:  J Schauber; B Homey; M Steinhoff
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751

8.  Ocular Demodex folliculorum: prevalence and associated symptoms in an Irish population.

Authors:  Orla Murphy; Veronica O'Dwyer; Aoife Lloyd-McKernan
Journal:  Int Ophthalmol       Date:  2018-01-29       Impact factor: 2.031

9.  Occurrence of Demodex species in patients with blepharitis and in healthy individuals: a 10-year observational study.

Authors:  Monika Maria Biernat; Jolanta Rusiecka-Ziółkowska; Elżbieta Piątkowska; Iwona Helemejko; Paweł Biernat; Grażyna Gościniak
Journal:  Jpn J Ophthalmol       Date:  2018-09-25       Impact factor: 2.447

10.  Effect of topical loteprednol etabonate with lid hygiene on tear cytokines and meibomian gland dysfunction in prosthetic eye wearers.

Authors:  J S Ko; Y Seo; M K Chae; S Y Jang; J S Yoon
Journal:  Eye (Lond)       Date:  2017-10-20       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.